|
A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. Clinical research trials and A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients.. A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. clinical trial. Test subjects typically receive the most effective healthcare possible for their A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients.  A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients.
A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients.
For Condition: HIV Infections
Status: Completed
Sponsor(s): Sponsor Name Pending ,
Synopsis: This study will evaluate the drop in viral load over 10 days of treatment with S-1360 versus placebo in HIV-infected patients who have not previously taken anti-HIV medications.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: (Subjects must meet the following criteria in order to be eligible for this study.): - No prior HIV medications. - HIV infection with viral load >400-50,000 copies/mL - CD4 cell count >50 cells/mm - Male or female - At least 18 years of age
Total Enrollment:
Location and Contact Information:
Study Site
Chapel Hill, North Carolina, 27599
United States
Study Site
Phoenix, Arizona, 85006
United States
Study Site
New York City, New York, 10008
United States
Study Site
Minneapolis, Minnesota, 55404
United States
Study Site
New York City, New York, 10011
United States
Study Site
Miami, Florida, 33133
United States
Study Site
Washington D.C., District of Columbia, 20007
United States
Study Site
West Hollywood, California, 90069
United States
Study Site
Tampa, Florida, 33614
United States
Study Site
New York City, New York, 10032
United States
Study Site
Indianapolis, Indiana, 46202
United States
Study Site
Ft. Lauderdale, Florida, 33311
United States
Study Site
San Francisco, California, 94115
United States
Study Site
Denver, Colorado, 80220
United States
Study Site
San Diego, California, 92103
United States
Study Site
Houston, Texas, 77004
United States
Study Site
Charlotte, North Carolina, 28203
United States
Study Site
Bronx, New York, 10461
United States
Study Site
Durham, North Carolina, 27710
United States
Study Site
Los Angeles, California, 90048
United States
Study Site
Atlanta, Georgia, 30308
United States
Study Site
Altamonte Springs, Florida, 32701
United States
Study Site
Dallas, Texas, 75235
United States
Additional Information:
Study ID Numbers: ITG20001;
Study Start Date:
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00046332
Other Hiv Infections Studies:
1. A Study of PMPA in HIV-Infected Patients
2. The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs
3. A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients with AIDS Who Have Already Been Treated with Ganciclovir
4. Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children
5. The Effects of AZT and Ibuprofen on HIV-Infected Patients with Hemophilia
Related Studies:
Other HIV Infections Clinical Trials
Other California Clinical Trials
Other San Diego Clinical Trials
A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients.
|
|
|
|
|
|
|
|
